Glycemia reduction in type 2 diabetes—Hypoglycemia outcomes: A randomized clinical trial

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-11-15
DOI
https://doi.org/10.1371/journal.pone.0309907
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glycemia reduction in type 2 diabetes—Hypoglycemia outcomes: A randomized clinical trial

Naji Younes, Jill P. Crandall, M.R. Gramzinski, Daniel S. Hsia et al.
1 citations
PLoS ONE
Diabetes Treatment and Management
0.36
article

Glycemia reduction in type 2 diabetes—Hypoglycemia outcomes: A randomized clinical trial

Naji Younes, Jill P. Crandall, M.R. Gramzinski, Daniel S. Hsia, Alokananda Ghosh, Andrea Waltje, Chelsea Baker, Richard M. Bergenstal, John M. Lachin, Lawrence S. Phillips, Robin Goland, Sophia H. Hox, Elizabeth R. Seaquist, Willy Marcos Valencia, Mary L. Johnson, P. Raskin
article en
1 citations

Abstract

No abstract available for this paper.
PLoS ONEVol. 19(11)
Pennington Biomedical Research Center (US), Albert Einstein College of Medicine (US), University of Minnesota (US), Milken Institute (US), Cleveland Clinic (US), University of Miami (US), Emory University (US), George Washington University (US), Florida International University (US), University of Michigan (US), Geriatric Research Education and Clinical Center (US), VA Pacific Islands Health Care System (US), Atlanta VA Medical Center (US), Southwestern Medical Center (US), HealthPartners (US), Columbia University (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
American Diabetes Association, U.S. Department of Veterans Affairs, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Vertex Pharmaceuticals, Bigfoot Biomedical, MannKind Corporation, Dexcom, Kowa Company, Novo Nordisk, National Institutes of Health, Centers for Disease Control and Prevention, Abbott Diabetes Care, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Janssen Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 32%
Diabetes Treatment and Management
0.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.